Gynecologic malignancies in pregnancy: Balancing fetal risks with oncologic safety Journal Article


Authors: Cordeiro, C. N.; Gemignani, M. L.
Article Title: Gynecologic malignancies in pregnancy: Balancing fetal risks with oncologic safety
Abstract: Importance: Cancer occurs in 0.05% to 0.1% of all pregnancies. Despite literature reporting good oncologic and fetal outcomes in women treated for cancer during pregnancy, as many as 44% of gynecologists would offer termination, and 37% would not administer chemotherapy or radiotherapy in pregnancy. Objectives: The aims of this study were to summarize current recommendations for the treatment of cervical and ovarian cancers in pregnancy and to review updates on existing knowledge regarding the safety of surgical and chemotherapeutic treatments in pregnancy, including both oncologic and fetal outcomes. Evidence Acquisition: A detailed literature review was performed on PubMed. Results: The treatment of gynecologic malignancies during pregnancy mirrors that outside pregnancy, with a balance between maternal versus fetal health. Fertility-sparing surgery can be offered to stage IA2 and low-risk IB1 cervical, stage I epithelial ovarian, germ cell ovarian, or sex-cord stromal ovarian tumors. Delayed treatment can be offered for stage IB1 cervical cancer. Neoadjuvant and/or adjuvant chemotherapy can be given for advanced gynecologic cancers with good disease-free survival without significant adverse neonatal outcomes. Conclusions: A multidisciplinary approach and improved education of providers regarding the surgical and chemotherapeutic treatments in pregnancy are needed in order to fully inform patients regarding treatment options. Further research in women who are pregnant is needed to determine the safety of diagnostic and therapeutic procedures used in the nonpregnant woman. Relevance: This article reviews and supports treatment of gynecologic cancer during pregnancy, calls for additional study and long-term follow-up, and justifies improved education of patients and providers regarding treatment options. Target Audience: Obstetricians and gynecologists, family physicians. Learning Objectives: After completing this activity, the learner should be better able to (1) review general principles in the management and treatment of gynecologic cancers in pregnancy, (2) review the diagnosis and treatment of cervical cancer in pregnancy, and (3) review the diagnosis and treatment of ovarian cancer in pregnancy. © 2017 Wolters Kluwer Health, Inc. All rights reserved.
Keywords: antineoplastic agents; chemotherapy, adjuvant; cancer staging; antineoplastic agent; neoplasm staging; ovarian neoplasms; practice guideline; pathology; time factors; adjuvant chemotherapy; practice guidelines as topic; pregnancy; fetus; uterine cervical neoplasms; pregnancy complications, neoplastic; pregnancy outcome; adverse effects; time factor; drug effects; humans; human; female
Journal Title: Obstetrical and Gynecological Survey
Volume: 72
Issue: 3
ISSN: 0029-7828
Publisher: Lippincott Williams & Wilkins  
Date Published: 2017-03-01
Start Page: 184
End Page: 193
Language: English
DOI: 10.1097/ogx.0000000000000407
PUBMED: 28304416
PROVIDER: scopus
PMCID: PMC5358514
DOI/URL:
Notes: Article -- Export Date: 3 April 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mary L Gemignani
    218 Gemignani